Globus Medical Q4 sales hit $826.4M, up 25.7%, driven by spine growth and successful NuVasive, Nevro integrations; analysts ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsBrian Kearns - Senior Vice President of ...

AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology ...

Q4 2025 earnings call recap: revenue/EPS beats, margin expansion, Nevro integration, and raised 2026 guidance—read key ...

Globus Medical cites successful integration of NuVasive and Nervo and strong domestic spine sales growth as drivers in strong Q4 results.

Medical device company Globus Medical (NYSE:GMED) will be reporting results this Tuesday after market close. Here’s what to ...

The medical device specialty segment has underperformed recently, with share prices down 3.4% on average over the past month, though Globus has fared relatively better. The stock currently trades at ...

Globus Medical expects full-year earnings in the range of $4.40 to $4.50 per share, with revenue in the range of $3.18 billion to $3.22 billion. This story was generated by Automated Insights ( http:/ ...

Medical device company Globus Medical (NYSE:GMED) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 25.7% year on year to $826.4 million. The company’s full-year revenue ...

Globus Medical saw nearly $3 billion in full-year net sales, according to financial results posted Feb. 24. Five things to know: 1. Net sales in 2025 were $2.93 billion, an increase of 16.7% year over ...

Nasarawa State Governor, Abdullahi Sule has reaffirmed his administration’s commitment to continue to foster an enabling environment for businesses to thrive in order to ensure success for business ...

Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting results tomorrow before market open. Here’s what you need to know.